A phase 1-2 trial of diethylstilbestrol plus low dose warfarin in advanced prostate carcinoma

Journal of Urology

Volumn 161, Issue 1, 1999, Pages 169-172

  Klotz, Laurence ^a   McNeill, Irene ^a   Fleshner, Neil ^a  

^a NONE

Author keywords

Diethylstilbestrol; Prostate adenocarcinoma; Warfarin

Indexed keywords

BLOOD CLOTTING FACTOR 7; DIETHYLSTILBESTROL; TESTOSTERONE; WARFARIN;

ADULT; ADVANCED CANCER; AGED; ANTICOAGULATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; EDEMA; GYNECOMASTIA; HEART INFARCTION; HUMAN; MALE; MASTALGIA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE CARCINOMA; TESTOSTERONE BLOOD LEVEL; THORAX PAIN; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK;

EID: 0032862847     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)62089-5     Document Type: Article

References (13)

1. Huggins, C., Stevens, R. E. and Hodges, C. V.: Studies in prostate cancer: the effect of castration in advanced carcinoma of the prostate. Arch. Surg., 43: 209, 1941.
2. Treatment and survival of patients with cancer of the prostate. The Veterans Administration Co-operative Urological Research Group. Surg. Gynec. Obst., 124: 1011, 1967.
3. Byar, D. P.: Proceedings: the Veterans Administration Cooperative Urological Research Group's studies of cancer of the prostate. Cancer, 32: 1126, 1973.
4. Robinson, M. R. and Thomas, B. S.: Effect of hormonal therapy on plasma testosterone levels in prostatic carcinoma. Brit. Med. J., 4: 391, 1971.
5. Leuprolide versus diethylstilbestrol for metastatic prostate cancer. The Leuprolide Study Group. New Engl. J. Med., 311: 1281, 1984.
6. deVoogt, H. J., Smith, P. H., Pavone-Macaluso, M., de Pauw, M. and Suciu, S.: Cardiovascular side effects of diethylstilbestrol, cyproterone acetate, medroxyprogesterone acetate and estramustine phosphate used for the treatment of advanced prostatic cancer: results from European Organization for Research on Treatment of Cancer trials 30761 and 30762. J. Urol., 135: 303, 1986.
7. Chang, A., Yeap, B., Davis, T., Blum, R., Hahn, R., Khanna, O., Fisher, H., Rosenthal, J., Witte, R., Schinella, R. and Trump, D.: Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: flutamide versus diethylstilbestrol. J. Clin. Oncol., 14: 2250, 1996.
8. Hasui, Y., Marutsuka, K., Nishi, S., Kitada, S., Osada, Y. and Sumiyoshi, A.: The relationship between cardiovascular complications of estrogen therapy and fibrinolysis in patients with prostatic cancer. Prostate, 21: 35, 1992.
9. Wessler, S. and Gitel, S.: Thrombotic complications of oral contraceptives. In: Haemostasis and Thrombosis: Basic Principles and Clinical Practice, 2nd ed. Edited by R. Coleman, J. Hirsch, V. Marder and E. Salzman. Philadelphia: J. B. Lippincott Co., chapt. 74, pp. 1158-1183, 1982.
10. Poller, L., McKernan, A., Thomson, J. M., Elstein, M., Hirsch, P. J. and Jones, J. B.: Fixed minidose warfarin: a new approach to prophylaxis against venous thrombosis after major surgery. Brit. Med. J., 295: 1309, 1987.
11. Conway, E. M., Bauer, K. A., Barzegar, S. and Rosenberg, R. D.: Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses. J. Clin. Invest., 80: 1535, 1987.
12. Bern, M., Lokich, J. J., Wallach, S. R., Bothe, A., Jr., Benotti, P. N., Arkin, C. F., Greco, F. A., Huberman, M. and Moore, C.: Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Ann. Intern. Med., 112: 423, 1990.
13. MacCallum, P. K., Thomson, J. M. and Poller, L.: Effect of fixed minidose warfarin on coagulation and fibrinolysis following major gynaecological surgery. Thromb. Haemost., 64: 511, 1990.